Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06849791

A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants

Assessment of the Relative Bioavailability of ABBV-932 Formulations in Healthy Adult Subjects

Status
Active Not Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
9 (actual)
Sponsor
AbbVie · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study will assess the relative bioavailability and effect of food on pharmacokinetics of ABBV-932 oral administration in healthy adult participants.

Conditions

Interventions

TypeNameDescription
DRUGABBV-932Oral Capsule
DRUGABBV-932Oral tablet

Timeline

Start date
2025-02-26
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2025-02-27
Last updated
2026-02-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06849791. Inclusion in this directory is not an endorsement.